Private Ocean, LLC Gilead Sciences, Inc. Transaction History

Private Ocean, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$64.88 - $73.64 $259 - $294	-4 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $26,805 - $28,919	-396 Reduced 99.0%	4 $0
Q2 2021 Aug 02, 2021	SELL	$63.47 - $69.35 $253 - $277	-4 Reduced 0.99%	400 $28,000
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $10,423 - $11,877	-184 Reduced 31.29%	404 $24,000
Q2 2020 Jul 24, 2020	BUY	$72.34 - $84.0 $289 - $336	4 Added 0.68%	588 $45,000
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $11,523 - $14,760	184 Added 46.0%	584 $43,000
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $6,251 - $6,900	-100 Reduced 20.0%	400 $26,000
Q2 2019 Jul 30, 2019	SELL	$61.87 - $69.38 $12,374 - $13,876	-200 Reduced 28.57%	500 $33,000
Q4 2018 Jan 31, 2019	SELL	$60.54 - $79.0 $8,172 - $10,665	-135 Reduced 16.17%	700 $44,000
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $11,224 - $13,092	-173 Reduced 17.16%	835 $59,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $2,986 - $3,640	-41 Reduced 3.91%	1,008 $75,000
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $10,601 - $12,444	149 Added 16.56%	1,049 $75,000
Q2 2017 Aug 08, 2017	BUY	N/A	900	900 $64,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Private Ocean, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Ocean, LLC with notifications on news.